These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 4115559)

  • 1. Clinical experience with Glibenclamide--Daonil.
    Breidahl HD
    Aust N Z J Med; 1971 Aug; 1():Suppl 2:63-6. PubMed ID: 4115559
    [No Abstract]   [Full Text] [Related]  

  • 2. Glibenclamide (HB 419, Daonil) in the clinical practice of diabetes.
    Krall LP; Sinha S; Goldstein HH
    Aust N Z J Med; 1971 Aug; 1():Suppl 2:57-62. PubMed ID: 5005132
    [No Abstract]   [Full Text] [Related]  

  • 3. Clinical experiences in oral antidiabetic therapy with sulphonylureas and biguanides.
    Schöffling K
    Aust N Z J Med; 1971 Aug; 1():Suppl 2:47-56. PubMed ID: 5005131
    [No Abstract]   [Full Text] [Related]  

  • 4. Experience with a new hypoglycemic agent, glibenclamide, HB 419 (Daonil) in diabetes mellitus.
    Ser I
    Isr J Med Sci; 1972 Jun; 8(6):887. PubMed ID: 4626318
    [No Abstract]   [Full Text] [Related]  

  • 5. [Diabetes: new drugs?].
    Codaccioni JL; Fontaine G
    Sem Hop; 1976 May; 52(20):1243-5. PubMed ID: 189407
    [No Abstract]   [Full Text] [Related]  

  • 6. [Thyroid function in diabetics treated with sulfonylurea and biguanides].
    Kasperska-Czyzykowa T; Czech W; Sawicki Z; Woy-Wojciechowski J; Zuławnik W
    Pol Arch Med Wewn; 1978 Mar; 59(3):275-83. PubMed ID: 580962
    [No Abstract]   [Full Text] [Related]  

  • 7. Clinical comparison between glipentide (Staticum) and glibenclamide in diabetics.
    Moncada Lorenzo E; Garcia RV; Barberia Layana JJ; Morant Ciscard JA; Calleja Canelas A
    Curr Ther Res Clin Exp; 1977 Jan; 21(1):50-7. PubMed ID: 401712
    [No Abstract]   [Full Text] [Related]  

  • 8. [Glibenclamide (Daonil Euglucon)].
    Frey H
    Tidsskr Nor Laegeforen; 1971 Aug; 91(24):1766-7. PubMed ID: 4999954
    [No Abstract]   [Full Text] [Related]  

  • 9. Oral management of uncomplicated maturity onset diabetes.
    Mashaly M; el-Ebrashy N; Higazi AM; Einen MA; Aziz MT
    J Egypt Med Assoc; 1974; 57(7-8):288-97. PubMed ID: 4217809
    [No Abstract]   [Full Text] [Related]  

  • 10. [Biguanides in the treatment of obesity].
    Giulietti M
    Clin Ter; 1978 Jan; 84(1):99-100. PubMed ID: 415837
    [No Abstract]   [Full Text] [Related]  

  • 11. Treatment with glibenclamide in maturity-onset diabetes mellitus.
    Persson I; Madsen SN
    Geriatrics; 1971 May; 26(5):182-95. PubMed ID: 5004113
    [No Abstract]   [Full Text] [Related]  

  • 12. Pharmacological comparison between tolbutamide and two second generation hypoglycemic sulfonylureas (glibenclamide and glisoxepide).
    Loubatiéres A; Mariani MM; Ribes G; Alric R
    Acta Diabetol Lat; 1973; 10(2):261-82. PubMed ID: 4200675
    [No Abstract]   [Full Text] [Related]  

  • 13. Clinical studies with glibenclamide at the Prince of Wales Hospital, New South Wales.
    Steinbeck AW
    Aust N Z J Med; 1971 Aug; 1():Suppl 2:72-6. PubMed ID: 5005134
    [No Abstract]   [Full Text] [Related]  

  • 14. [Our observations on diabetics treated with glibenclamide].
    Pogátsa G
    Orv Hetil; 1976; 117(20):1215-7. PubMed ID: 818596
    [No Abstract]   [Full Text] [Related]  

  • 15. [Thyroid gland function of patients with diabetes in long-term use of glibornuride].
    Reinwein D
    Arzneimittelforschung; 1972 Dec; 22():Suppl 12A:2221. PubMed ID: 4125093
    [No Abstract]   [Full Text] [Related]  

  • 16. Biguanides. Mode of action and role in the up-to-date treatment of diabetes mellitus.
    Fövényi J
    Ther Hung; 1971; 19(2):43-8. PubMed ID: 5172874
    [No Abstract]   [Full Text] [Related]  

  • 17. [Glibenclamide and diabetes mellitus. 1. Year's clinical experience].
    Contreras AR; Gabrielli S; Baigorria L
    Prensa Med Argent; 1972 May; 59(15):581-3. PubMed ID: 4626172
    [No Abstract]   [Full Text] [Related]  

  • 18. [Preliminary clinical experiences and problems of long-term therapy of diabetes mellitus using 2nd generation sulfonylurea derivatives (glibenclamide)].
    Schilling I; Bruns W; Haller H; Mehnert E; Mohnike A; Jutzi E; Schliack V; Schulze J
    Z Gesamte Inn Med; 1973 May; 28(10):Suppl 10:149-5. PubMed ID: 4200337
    [No Abstract]   [Full Text] [Related]  

  • 19. [Clinical study of a new sulfonylurea antidiabetic, glibornuride].
    Vernet A; Fabre J; Zahnd G
    Schweiz Rundsch Med Prax; 1972 Dec; 61(52):1599-607. PubMed ID: 4630563
    [No Abstract]   [Full Text] [Related]  

  • 20. [Glibenclamide: its therapeutic effect in diabetes mellitus].
    Concha E; Veit O
    Rev Med Chil; 1971 Mar; 99(3):217-9. PubMed ID: 4999506
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.